Japanese stocks have rallied to their highest level of the year during the Asian session following the Bank of Japan meeting overnight which saw the central bank maintain their dovish rhetoric despite a recent sharp drop in the Yen. However this has failed to provide any significant moves higher for the UK stock market with the FTSE 100 seemingly already in holiday mode and lower by 9 points but remaining above the big psychological level of 7000. The pound is little changed on the day, with the only substantial move against a major pair being the rise against the Yen that is more down to weakness in the Japanese currency.

Housebuilders look to rise into year-end

The best performing stock on the FTSE 100 so far today is Barratt Developments, with shares in the homebuilder rising by approximately 1.5%. It has been a challenging six months for the firm with the shock outcome of the Brexit vote seeing large scale selling in the stock, but investors will hope that after the initial panic price has found some support and could look to end the year on the front foot. Taylor Wimpey is also enjoying a fair size gain this Tuesday, rising by 0.6% so far. Banking shares have experienced volatile trade in recent weeks with fears surrounding the solvency of their Italian counterparts seeing wild swings in London due to contagion fears. Disaster has been averted thus far and Lloyds, Barclays and RBS are all seeking to continue their recent rally which comes as a welcome relief following a tough year for shareholders.

Gold stocks lose their shine

After a stellar performance in the first half of the year, Fresnillo and Randgold Resources have seen some selling in recent months and both are continuing lower today with the former residing at the bottom of the FTSE 100. A global push higher in yields, which began stateside following Trump's victory shows little signs of ending anytime soon and this makes non-yielding assets such as gold relatively less attractive. The Pharmaceuticals sector is seeing some mixed performance this morning with AstraZeneca and Johnson Matthey performing well, whilst Hikma Pharmaceuticals is selling off.

CFD’s, Options and Forex are leveraged products which can result in losses that exceed your initial deposit. These products may not be suitable for all investors and you should seek independent advice if necessary.

Analysis feed

Latest Forex Analysis

Editors’ Picks

EUR/USD hits two-month lows amid USD strength

EUR/USD has pared its gains that followed upbeat preliminary PMIs for Germany came out above expectations, pointing to a recovery. The USD is advancing amid fears of the coronavirus.


GBP/USD drops below 1.31 amid USD strength, fails to sustain PMI gains

GBP/USD is trading below  1.31 after hitting a fresh high of 1.3172. The UK Manufacturing PMI beat with 49.8 and Services PMI with 52.9. The USD is gaining ground across the board.


Cryptos: Bears take over and draw a bloody moon

Despite appearances, Bitcoin is the asset with the best risk/benefit ratio. The current falls are adjusted to the ranges of the previous rise. Downward momentum expires in the first half of February.

Read more

Gold rebounds above $1560

The XAU/USD pair dropped to a daily low of $1556.70 during the European trading hours as the easing worries over coronavirus becoming a global epidemic and a broad-based USD strength put the pair under bearish pressure.

Gold News

USD/JPY drops to two-week lows near 109.30

The USD/JPY pair reversed its direction during the American trading hours as the risk-off atmosphere allowed the JPY to find demand as a safe-haven.


Forex Majors